Novo Nordisk Brings World’s First Once-Weekly Basal Insulin Awiqli to India
Novo Nordisk has launched Awiqli (insulin icodec), the world’s first once-weekly basal insulin, in India, marking a significant advancement in […]
Novo Nordisk has launched Awiqli (insulin icodec), the world’s first once-weekly basal insulin, in India, marking a significant advancement in […]
FIT Insulin Injection Day was observed in Delhi, with the release of new recommendations for insulin injection usage and a […]
Now, irrespective of the brand, all domestically-produced insulin would cost between Rs135-145 per packet New Delhi: The Government of […]
Forum for Injection Techniques (FIT India) in association with BD (Becton, Dickinson and Company), launched the first Indian clinical recommendations for […]
[This article was published in the May 2009 issue of the eHEALTH Magazine (https://www.ehealthonline.org)]
Technology is becoming a critical factor in monitoring patients with speed and accuracy.
Biotechnology company Shreya Lifesciences has entered into an in-licensing agreement with US-based Generex Biotechnology Corp to market Oral-lyn, the country
[This article was published in the March 2007 issue of the eHEALTH Magazine (https://www.ehealthonline.org)]
Every year thousands of ICU patients develop atypical physiological symptoms, which keep them ill longer than necessary.